Research Funding

Research group of xenobiochemistry and pathobiochemistry of liver

Ongoing

Technology Agency of the Czech Republic

SS06020173 "Metody snižující rizika cirkulace veterinárních léčiv v životním prostředí" (2023-2025)

Projekt je spolufinancován se státní podporou Technologické agentury ČR v rámci Národního plánu obnovy z evropského Nástroje pro oživení a odolnost.

Charles University Research Funding

GAUK No. 153324 "Úloha glutathionperoxidasy 7 a její epigenetická regulace v progresi nealkoholové tukové choroby jater in vivo" (2024-2026)

European Union, European Structural and Investment Funds

New Technologies for Translational Research in Pharmaceutical Sciences /NETPHARM (2024-2028)
Project No: CZ.02.01.01/00/22_008/0004607; within the Operation Programme Johannes Amos Comenius, Priority 1 - Research and development, Specific target 1.1 Development and strengthening of research and innovation capacities and implementation of advanced technologies; OP RDE Call: No. 02_22_008 Excellent Research

Past

Czech Science Foundation

18-09946S "Metabolism of terpenes and mechanisms of their toxic effects in human liver"
18-08452S “Anthelmintics in plants – interactions with polyphenols biosynthesis and antioxidant defence”
P503/15-05325S “Anthelmintics in plants – uptake, biotransformation and transcriptional response“
P303/12/G163 “Centre of drug - dietary supplement interactions and nutrigenetics”
524/09/P121 “Modification of enzymes metabolizing xenobiotics during ageing”

Charles University Research Funding

GAUK No. 318422 "Epigenetic changes in progression of non-alcoholic fatty liver disease"
GAUK No. 240121 "Changes in the expression and activities of detoxification enzymes in non-alcoholic fatty liver disease"
START/MED/065 "Novel therapeutic approaches to the treatment of hepatic diseases"
GAUK No. 1302120 "The investigation of biotransformation of reactive sesquiterpenes and their effect on the proteome of human hepatic cells"

European Union, European Structural and Investment Funds

Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods – New Challenges (EFSA–CDN);
Project No: CZ.02.1.01/0.0/0.0/16_019/0000841; within the Operation Program Research, Development and Education (OP RDE), PA 1, IP 1, SO 1; OP RDE call: No. 02_16_019 Excellent Research